Related Experiment Video
Updated: Feb 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease
Joseph Lunyera1, Julia J Scialla2
1Department of Medicine, Duke University School of Medicine, Durham, NC.
Insights
Chronic kidney disease mineral and bone disorder (MBD) is linked to cardiovascular disease. Precision medicine approaches may offer new therapeutic strategies for MBD, improving patient outcomes.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Chronic kidney disease mineral and bone disorder (MBD) involves widespread metabolic changes in kidney disease.
- MBD components are frequently associated with cardiovascular disease (CVD) in epidemiological studies.
- MBD may directly contribute to CVD through various mechanisms including hypertension and vascular calcification.
Purpose of the Study:
- To review the complex interactions within MBD and their link to CVD.
- To explore the challenges in MBD assessment and treatment.
- To discuss the potential of precision medicine in managing MBD and its cardiovascular complications.
Main Methods:
- Review of conventional and precision epidemiology in MBD.
- Analysis of potential mechanisms linking MBD to cardiovascular disease pathogenesis.
- Discussion of therapeutic principles for established and emerging treatments.
Main Results:
- MBD components, including mineral ions, vitamin D, FGF23, and PTH, exhibit complex biological interactions.
- These interactions present challenges for clinical trials and treatment translation.
- Precision medicine, genomics, and individualized risk assessment show promise for advancing MBD management.
Conclusions:
- MBD is a significant factor in cardiovascular disease associated with chronic kidney disease.
- The intricate nature of MBD necessitates advanced approaches like precision medicine.
- Further research and individualized therapies are crucial for effective MBD and CVD management in kidney disease patients.
Abstract:
Chronic kidney disease mineral and bone disorder (MBD) encompasses changes in mineral ion and vitamin D metabolism that are widespread in the setting of chronic kidney disease and end-stage renal disease. MBD components associate with cardiovascular disease in many epidemiologic studies. Through impacts on hypertension, activation of the renin-angiotensin-aldosterone system, vascular calcification, endothelial function, and cardiac remodeling and conduction, MBD may be a direct and targetable cause of cardiovascular disease. However, assessment and treatment of MBD is rife with challenges owing to biological tensions between its many components, such as calcium and phosphorus with their regulatory hormones fibroblast growth factor 23 and parathyroid hormone; fibroblast growth factor 23 with its co-receptor klotho; and vitamin D with control of calcium and phosphorus. These complex interactions between MBD components hinder the simple translation to clinical trials, which ultimately are needed to prove the benefits of treating MBD. Deeper investigation using precision medicine tools and principles, including genomics and individualized risk assessment and therapy, may help move the field closer toward clinical applications. This review provides a high-level overview of conventional and precision epidemiology in MBD, potential mechanisms of cardiovascular disease pathogenesis, and guiding therapeutic principles for established and emerging treatments.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

